CHICAGO (Reuters) - ResMed Inc's main competitor in the sleep apnea treatment market will soon be swallowed by Philips Electronics , throwing the spotlight on whether ResMed will remain independent.
A Philips Respironics System One unit in 2015. Philips reached a $1.1 billion settlement related to its Respironics sleep-apnea devices. (Jasper Juinen/Bloomberg News) Investors usually don't cheer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback